Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia 10Leukemia, Myeloid, Acute 7Congenital Abnormalities 6Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Myelodysplastic Syndromes 3Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Anemia, Refractory, with Excess of Blasts 2Thrombocytopenia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Burkitt Lymphoma 1Anemia, Refractory 1

Interventions

eltrombopag 9Platelet Transfusion 5Cytarabine 5Peripheral Blood Stem Cell Transplantation 3Daunorubicin 3fludarabine phosphate 2Tranexamic Acid 2Radiotherapy 2Lenalidomide 2Filgrastim 2Etoposide 2Cyclosporine 2Busulfan 2sargramostim 1oprelvekin 1ofatumumab 1leridistim 1bryostatin 1 1alvocidib 1Vitamin E 1Vincristine 1Transplantation 1Topotecan 1Thioguanine 1Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Prednisone 1Microarray Analysis 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × DNA Methylation × Other hematologic neoplasm × Clear all
NCT01165996 2019-03-04

Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome

Case Comprehensive Cancer Center

Phase 1/2 Completed
25 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡